Western blot analysis of HeLa cells, untreated or treated with Human Interferon-γ (hIFN-γ) #8901 (100 ng/ml, 4 hr), using IRF-1 (D5E4) XP ® Rabbit mAb.
Western blot analysis of extracts from various cell lines using IRF-1 (D5E4) XP ® Rabbit mAb.
Imunohistochemical analysis of paraffin-embedded human breast carcinoma using IRF-1 (D5E4) XP ® Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right).
Imunohistochemical analysis of paraffin-embedded human lymphoma using IRF-1 (D5E4) XP ® Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded mosue thymus using IRF-1 (D5E4) XP ® Rabbit mAb.
Imunohistochemical analysis of paraffin-embedded HeLa cell pellets, control (left) or IFN gamma-treated (right), using IRF-1 (D5E4) XP ® Rabbit mAb.
Confocal immunofluorescent analysis of HeLa cells, serum-starved (left) or treated with hIFNγ #8901 (100 ng/mL, 4 hr; right), using IRF-1 (D5E4) XP ® Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin.
Flow cytometric analysis of HeLa cells, untreated (blue) or treated with Human Interferon-γ (hIFN-γ) #8901 (green), using IRF-1 (D5E4) XP ® Rabbit mAb.